cobas HCV
FDA 510(k) K252484 · Roche Molecular Systems, Inc.
510(k) numberK252484
Submission
- Device name
- cobas HCV
- Applicant
- Roche Molecular Systems, Inc.
Pleasanton, CA, US - Received
- August 7, 2025
- Decision date
- November 3, 2025
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MZP – Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3170
- Specialty
- Microbiology
Other 510(k)s with product code MZP
More from Roche Molecular Systems, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K260047 | cobas Strep A Nucleic acid test for use on the cobas Liat System (07341911190); cobas…PGX · Traditional | 08/28/2026SE |
| K260045 | cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas®…OZN · Traditional | 08/28/2026SE |
| K260021 | cobas® BV/CVPQA · Traditional | 07/16/2026SE |
| K260917 | cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the…QEP · Traditional | 07/08/2026SE |
| K253759 | cobas liat CT/NG/MG nucleic acid testQEP · Dual Track | 05/15/2026SE |
| K253756 | cobas liat CT/NG nucleic acid testQEP · Dual Track | 05/15/2026SE |
| K243753 | cobas liat Bordetella panel nucleic acid testOZZ · Dual Track | 11/20/2025SE |
| K252481 | cobas CMVPAB · Traditional | 11/03/2025SE |
| K243455 | cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 SystemsQOF · Traditional | 07/31/2025SE |
| K243863 | Opulus Lymphoma PrecisionQIH · Traditional | 05/30/2025SE |
Questions and answers
When was cobas HCV cleared by the FDA?
cobas HCV (K252484) received a 510(k) decision of Substantially Equivalent on November 3, 2025, 88 days after the submission was received.
What is the product code of K252484?
The FDA product code is MZP – Assay, Hybridization And/Or Nucleic Acid Amplification For Detection Of Hepatitis C Rna,Hepatitis C Virus, a Class II (moderate risk) device regulated under 21 CFR 866.3170.